Trials / Conditions / Cryopyrin-associated Periodic Syndromes (CAPS)
Cryopyrin-associated Periodic Syndromes (CAPS)
4 registered clinical trials studyying Cryopyrin-associated Periodic Syndromes (CAPS) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Study to Evaluate the Safety, Tolerability, Efficacy and Pharmacokinetics of JTE-162 in Subjects With Cryopyri NCT07247266 | Akros Pharma Inc. | Phase 1 |
| Recruiting | Ilaris NIS in Korea NCT06838143 | Novartis Pharmaceuticals | — |
| Terminated | HL2351 CAPS Phase II Study NCT02853084 | Handok Inc. | Phase 2 |
| Completed | Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients NCT01213641 | Novartis Pharmaceuticals | — |